The efficacy of Roxadustat for the treatment of anemia in dialysis dependent chronic kidney disease patients: an updated systematic review and meta-analysis of randomized clinical trials

BACKGROUND: Anemia is a common complication in chronic kidney disease (CKD) with increased morbidity and mortality. Recently published RCTs were conducted to compare the effect of the new medication roxadustat (ROX) with erythropoiesis-stimulating agent (ESA) in dialysis-dependent CKD (DD-CKD) patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelazeem, Basel, Abbas, Kirellos Said, Shehata, Joseph, El-Shahat, Nahla Ahmed, Baral, Nischit, Savarapu, Pramod, Kunadi, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743719/
https://www.ncbi.nlm.nih.gov/pubmed/35071408
http://dx.doi.org/10.21037/atm-21-4357

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8743719/
https://www.ncbi.nlm.nih.gov/pubmed/35071408
http://dx.doi.org/10.21037/atm-21-4357

Ejemplares similares